The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Novartis admitted the email broke several rules set out in the U.K. marketing code. In a long response to the PMCPA, the ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

With solid Phase 1b data, limited deal risk, and a $7 payout on a $0.90 CVR, the special situation offers an attractive setup ...

The rapid addition of small interfering RNA therapy to usual care after a recent ACS helps more patients achieve recommended ...

Atacicept met its Phase 3 proteinuria reduction endpoint, supporting optimism for Vera's accelerated FDA approval filing ...

The global immuno-oncology market is set to witness a growth rate of 21% in the next 5 years. Increasing incidence and ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, June 04, 2025--Biocom California, the association representing the California life science industry, today announced the appointment of Thierry ...

Dietary patterns seem to be associated with depressive symptoms, according to a study published online June 3 in BMJ ...

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...